Robert W. King

1.4k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Robert W. King is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Robert W. King has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Robert W. King's work include Hepatitis B Virus Studies (9 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis C virus research (5 papers). Robert W. King is often cited by papers focused on Hepatitis B Virus Studies (9 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis C virus research (5 papers). Robert W. King collaborates with scholars based in United States, Switzerland and France. Robert W. King's co-authors include Stephanie K. Ladner, Michaël Otto, Katie Zaifert, Ju‐Tao Guo, Christopher S. Barker, Christoph Seeger, Thomas Miller, Robert B. Perni, Carol Reid and Ronald M. Klabe and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and American Journal of Obstetrics and Gynecology.

In The Last Decade

Robert W. King

29 papers receiving 1.1k citations

Hit Papers

Inducible expression of human hepatitis B virus (HBV) in ... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. King United States 15 780 572 328 239 167 29 1.1k
Annie Cahour France 19 402 0.5× 501 0.9× 332 1.0× 276 1.2× 130 0.8× 44 1.2k
J C Pugh United States 16 877 1.1× 556 1.0× 358 1.1× 193 0.8× 106 0.6× 23 1.1k
J. L. Gerin United States 17 938 1.2× 643 1.1× 309 0.9× 167 0.7× 101 0.6× 27 1.2k
Gennadiy Koev United States 19 564 0.7× 703 1.2× 429 1.3× 237 1.0× 72 0.4× 25 1.3k
William E. Hornbuckle United States 20 1.1k 1.4× 750 1.3× 287 0.9× 207 0.9× 89 0.5× 35 1.4k
Dean Clarke United Kingdom 6 456 0.6× 475 0.8× 148 0.5× 240 1.0× 48 0.3× 6 825
Shihyun You United States 14 466 0.6× 485 0.8× 434 1.3× 414 1.7× 264 1.6× 21 1.4k
Lucy Beales United Kingdom 11 429 0.6× 423 0.7× 166 0.5× 298 1.2× 42 0.3× 14 958
Celso Cunha Portugal 18 379 0.5× 303 0.5× 303 0.9× 447 1.9× 64 0.4× 43 1.2k
Peter Friebe Germany 14 923 1.2× 1.3k 2.2× 364 1.1× 578 2.4× 266 1.6× 16 1.9k

Countries citing papers authored by Robert W. King

Since Specialization
Citations

This map shows the geographic impact of Robert W. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. King more than expected).

Fields of papers citing papers by Robert W. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. King. The network helps show where Robert W. King may publish in the future.

Co-authorship network of co-authors of Robert W. King

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. King. A scholar is included among the top collaborators of Robert W. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. King. Robert W. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kueffer, Thomas, Sven Knecht, Xavier Waintraub, et al.. (2025). Pulsed-Field vs Thermal Catheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. JACC. Clinical electrophysiology. 11(6). 1205–1215. 1 indexed citations
2.
Kueffer, Thomas, Robert W. King, Gregor Thalmann, et al.. (2025). Beyond the learning curve: How operator experience affects pulsed-field ablation outcomes. Heart Rhythm. 1 indexed citations
3.
Kueffer, Thomas, Robert W. King, George N. Thalmann, et al.. (2025). Pulsed field ablation for index pulmonary vein isolation: 3-year learning curve and the influence of adjunctive 3D mapping. EP Europace. 27(Supplement_1). 1 indexed citations
4.
Heins, Brad, et al.. (2018). Effects of winter housing systems on production, economics, body weight, body condition score, and bedding cultures for organic dairy cows. Journal of Dairy Science. 102(1). 706–714. 10 indexed citations
5.
King, Robert W.. (2004). Gene Delivery to Mammalian Cells by Microinjection. Humana Press eBooks. 245. 167–174. 28 indexed citations
6.
Carrion, Miguel, Melissa Hamilton, Brent T. Harris, et al.. (2003). Ocular Sublocalization and Pharmacokinetics of Expression of Pigment Epithelium-Derived Factor in Murine Eyes Following Adenovirus-Based Intravitreous Gene Delivery. Investigative Ophthalmology & Visual Science. 44(13). 3587–3587. 1 indexed citations
7.
King, Robert W. & Stephanie K. Ladner. (2003). Hep AD38 Assay: A High-Throughput, Cell-Based Screen for the Evaluation of Compounds Against Hepatitis B Virus. Humana Press eBooks. 24. 43–50. 4 indexed citations
8.
King, Robert W., Ronald M. Klabe, Carol Reid, & Susan Erickson‐Viitanen. (2002). Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 46(6). 1640–1646. 47 indexed citations
9.
Perni, Robert B., et al.. (2000). Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication. Bioorganic & Medicinal Chemistry Letters. 10(23). 2687–2690. 65 indexed citations
10.
King, Robert W.. (2000). 3rd International Conference on Therapies for Viral Hepatitis. Drug Resistance Updates. 3(1). 55–57. 1 indexed citations
11.
King, Robert W., et al.. (2000). Dextranase in sugar production: factory experience.. 20. 95–103. 13 indexed citations
12.
King, Robert W., Stephanie K. Ladner, Thomas Miller, et al.. (1998). Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- l -2′,3′-Dideoxy-3′-Thiacytidine. Antimicrobial Agents and Chemotherapy. 42(12). 3179–3186. 121 indexed citations
13.
Ladner, Stephanie K., Michaël Otto, Christopher S. Barker, et al.. (1997). Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrobial Agents and Chemotherapy. 41(8). 1715–1720. 517 indexed citations breakdown →
15.
King, Robert W. & Edward H. Simon. (1993). The Virion of Mengovirus Contains Anti-Interferon Activity. Journal of Interferon Research. 13(1). 1–7. 4 indexed citations
16.
Owens, Philip, Michael A. Conlon, R. G. Campbell, et al.. (1991). Developmental changes in growth hormone, insulin-like growth factors (IGF-I and IGF-II) and IGF-binding proteins in plasma of young growing pigs. Journal of Endocrinology. 128(3). 439–447. 41 indexed citations
17.
Hansky, J. & Robert W. King. (1977). Effect of Atropine on Food-Stimulated Gastrin Release After Truncal Vagotomy in Man. Gastroenterology. 73(2). 205–206. 8 indexed citations
18.
Allen, Fred H., et al.. (1963). The MN Gene MU, which Produces M and U but no N, S, or s*. Vox Sanguinis. 8(5). 549–556. 19 indexed citations
19.
King, Robert W., et al.. (1962). Environmental variables related to cervical cancer. American Journal of Obstetrics and Gynecology. 83(6). 720–728. 22 indexed citations
20.
King, Robert W., et al.. (1954). Carcinoma of the Meibomian Gland. American Journal of Ophthalmology. 37(2). 259–260. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026